Tania Shapiro-Barr
Partner & Patent Attorney

Alex Andrus - Senior Patent Counsel

Tania is a VHPM Partner and Patent Attorney with over 12 years of patent law experience working in the areas of medical devices, biotechnology, and pharmaceuticals. She provides patent and trademark counseling and portfolio management, and provides opinions regarding patentability, freedom-to-operate, infringement, and validity. Tania works with a variety of medical device and biotechnology clients, including Fortune 500 companies, mid-size and start-up companies, and university clients. She has authored a number of publications and given presentations on issues relating to life sciences IP.

Tania’s Favorite Outdoor Activity: Running

William Mitchell College of Law, J.D., 2008

University of Wisconsin Medical School, M.D., 2005

University of Wisconsin-Madison, B.S., Medical Microbiology and Immunology, 2001

Minnesota

Registered to practice before the United States Patent and Trademark Office

American Intellectual Property Law Association (AIPLA)

Association of University Technology Managers (AUTM)

“Medical Devices: The Interplay between Patent Law and the FDA Regulatory Process,” AUTM Webinar, January 24, 2023.

“3 Successful Strategies For Protecting Your New Biopharma’s IP,” Outsourced Pharma, September 1, 2021.

“Avoiding a catch-22,” Intellectual Property Magazine, June 30, 2021.

“The Intersection of Regulatory and Intellectual Property Issues in the Medical Device World,” Dykema Webinar, May 25, 2021.

“Intellectual Property Rights: Patent Basics and Strategies,” Institute for Biomedical Entrepreneurship, April 29, 2021.

“Collaboration in the Race to Find a Covid-19 Vaccine,” Intellectual Property Magazine, October 2, 2020.

“Biosimilars: Poised to Turn to Inter Partes Review to Resolve Patent Disputes,” Metropolitan Corporate Counsel, June 2015.

“In re Kubin: Federal Circuit Ignores Principles of Structural Obviousness in Applying ‘Obvious to Try’ Test,” Patent Strategy & Management, July, 2009.

“Federal Circuit Applies Bilski Standard in Classen,” Patent Strategy & Management, March, 2009.

“Ex Parte Kubin: Board of Patent Appeals and Interferences Applies ‘Obvious to Try’ in Post-KSR Biotechnology Appeal,” Patent Strategy & Management, January, 2009.

“Federal Circuit Split Decision on ‘Public Accessibility’ of Internet Posting,” Patent Strategy & Management, April, 2008.

952-876-4096
tshapirobarr@vhpmlaw.com

Resume

Contact us today to learn how we can help you.

GET IN TOUCH